New developments in the diagnosis and treatment of thyroid cancer

DF Schneider, H Chen - CA: a cancer journal for clinicians, 2013 - Wiley Online Library
Answer questions and earn CME/CNE Thyroid cancer exists in several forms. Differentiated
thyroid cancers include those with papillary and follicular histologies. These tumors exist …

Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis

A Sanabria, LP Kowalski, JP Shah, IJ Nixon… - Head & …, 2018 - Wiley Online Library
There is an increasing incidence of well‐differentiated thyroid cancer worldwide. Much of the
increase is secondary to increased detection of small, low‐risk tumors, with questionable …

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer

U Mallick, C Harmer, B Yap, J Wadsley… - … England Journal of …, 2012 - Mass Medical Soc
Background It is not known whether low-dose radioiodine (1.1 GBq [30 mCi]) is as effective
as high-dose radioiodine (3.7 GBq [100 mCi]) for treating patients with differentiated thyroid …

The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS …

CK Jung, MP Little, JH Lubin, AV Brenner… - The Journal of …, 2014 - academic.oup.com
Context: Thyroid cancer incidence rates in the United States and globally have increased
steadily over the last 40 years, primarily due to a tripling of the incidence of papillary thyroid …

A worldwide journey of thyroid cancer incidence centred on tumour histology

ED Rossi, L Pantanowitz, JL Hornick - The Lancet Diabetes & …, 2021 - thelancet.com
Over the past three decades, the incidence of thyroid carcinoma has been increasing
globally. Data from 2006 to 2012 indicate an annual incidence rate of thyroid cancer of …

An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer

IJ Nixon, LY Wang, JC Migliacci, A Eskander… - Thyroid, 2016 - liebertpub.com
Background: Age is a critical factor in outcome for patients with well-differentiated thyroid
cancer. Currently, age 45 years is used as a cutoff in staging, although there is increasing …

Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years

RW Randle, CJ Balentine, GE Leverson, JA Havlena… - Surgery, 2017 - Elsevier
Background The impact of recent medical advances on disease presentation, extent of
operation, and disease-specific survival for patients with medullary thyroid cancer is unclear …

Should all papillary thyroid microcarcinomas be aggressively treated?: an analysis of 18,445 cases

XM Yu, Y Wan, RS Sippel, H Chen - Annals of surgery, 2011 - journals.lww.com
Objective: The purpose of this study was to identify the risk factors that predict papillary
thyroid microcarcinoma (PTMC)-related death in a large patient population to determine …

Cytological features of “noninvasive follicular thyroid neoplasm with papillary-like nuclear features” and their correlation with tumor histology

F Maletta, F Massa, L Torregrossa, E Duregon… - Human pathology, 2016 - Elsevier
Among thyroid papillary carcinomas (PTCs), the follicular variant is the most common and
includes encapsulated forms (EFVPTCs). Noninvasive EFVPTCs have very low risk of …

Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods

JL Carter, RJ Coletti, RP Harris - Bmj, 2015 - bmj.com
Objective To determine the optimal method for quantifying and monitoring overdiagnosis in
cancer screening over time. Design Systematic review of primary research studies of any …